Literature DB >> 26711230

Effect of antipsoriatic therapy on oxidative stress index and sialic acid levels in patients with psoriasis.

Medha Rajappa1, Rathika Shanmugam2, Malathi Munisamy2, Laxmisha Chandrashekar2, Kalai Selvi Rajendiran1, Devinder Mohan Thappa2.   

Abstract

BACKGROUND AND OBJECTIVES: Recent studies have implicated the association between oxidative stress and inflammation in pathogenesis of psoriasis and its associated comorbidities. Hence, we undertook to study inflammatory markers such as sialic acids and the oxidative stress index (OSI) in patients with psoriasis vulgaris.
METHODS: Sixty cases and 60 healthy controls were included in this cohort study. Disease severity was assessed by psoriasis area severity index scoring. Serum levels of oxidative stress (total oxidant status, total antioxidant status) and inflammation (highly sensitive C-reactive protein [hs-CRP], total sialic acid, protein bound sialic acid) markers were estimated in controls and cases at baseline and on follow-up. OSI was calculated as the ratio of total oxidant status to total antioxidant status.
RESULTS: Baseline serum levels of OSI, hs-CRP, and sialic acids were significantly higher in cases compared to controls. Baseline OSI and sialic acids demonstrated a significant correlation with disease severity. After 12 weeks of therapy, there was a significant decline in OSI and serum levels of hs-CRP and sialic acids.
CONCLUSIONS: Our results demonstrate that oxidative stress and inflammation are significantly associated with psoriasis, and treatment with methotrexate results in a significant decline of both the inflammatory and oxidative stress parameters.
© 2015 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26711230     DOI: 10.1111/ijd.13196

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  4 in total

1.  Association of total oxidant status, total antioxidant status, and malondialdehyde and catalase levels with psoriasis: a systematic review and meta-analysis.

Authors:  YouCan Zhang; ZhongSheng Li; Yun Ma; Zhen Mu
Journal:  Clin Rheumatol       Date:  2019-07-18       Impact factor: 2.980

2.  Psoriasis & cardiovascular morbidity: The missing links?

Authors:  Satyaki Ganguly; Lopamudra Ray
Journal:  Indian J Med Res       Date:  2017-12       Impact factor: 2.375

3.  Evaluation of Serum Adenosine Deaminase and Inflammatory Markers in Psoriatic Patients.

Authors:  Yousry M Moustafa; Moustafa Ahmed Elsaied; Ehsan M Abd-Elaaty; Rasha A Elsayed
Journal:  Indian J Dermatol       Date:  2019 May-Jun       Impact factor: 1.494

4.  Astilbin reduces ROS accumulation and VEGF expression through Nrf2 in psoriasis-like skin disease.

Authors:  Wuyuntana Wang; Huan Wang
Journal:  Biol Res       Date:  2019-09-06       Impact factor: 5.612

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.